Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

4.900 USD +0.400 (+8.89%)
Official Closing Price Updated: 7:56 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Genprex Retains Addison Whitney for Drug Nomenclature Branding
Genprex Selects Addison Whitney for Drug Naming Agency. 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
New Gene Therapies Hold Out Promise for Patients
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
via NetworkNewsAudio -- Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene Therapy Programs to Watch in 2019.” 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for Cancer
From Newsfile Corp News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies
From Newsfile Corp News Releases
Potential Blockbuster Gene Therapy Programs to Watch in 2019
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
Genprex Collaborators Announce New Preclinical Data at AACR 
From Business Wire News Releases
Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
Genprex Announces Fourth Quarter Results and Year-End Update 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Advanced Medical Technologies Provides Unprecedented Targeting in Cancer... 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment
From Newsfile Corp News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy
From Newsfile Corp News Releases
Advanced Medical Technologies Provide Unprecedented Targeting in Cancer Therapy
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
via NetworkWire – NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces... 
From GlobeNewswire News Releases
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene Therapy
From Newsfile Corp News Releases
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene Therapy
via NetworkWire – NetworkNewsAudio announces the Audio Press Release (APR) titled “Making Profits, Saving Lives with Gene Therapy,” featuring Genprex Inc. (GNPX). 
From GlobeNewswire News Releases
32 Stocks Moving In Friday's Pre-Market Session
Gainers Achieve Life Sciences Inc (NASDAQ: ACHV) rose 96 percent to $4.80 in pre-market trading after the company reported a ... 
Tags SEEL MDCA DOCU
From Benzinga
Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
Genprex to Present at Upcoming ARM Cell & Gene Therapy Investor Day on March 21. 
From Business Wire News Releases
NetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market Profitability
via NetworkWire — NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring clinical-stage gene therapy company Genprex... 
From GlobeNewswire News Releases
Making Profits, Saving Lives With Gene Therapy
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Strengthens Senior Team and Continues to Advance Operations
Genprex New Hires Demonstrate Established Growth and Advancement 
From Business Wire News Releases
Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors
Genprex Adds Dr. John Bonfiglio to Board of Directors. 
From Business Wire News Releases
Genprex to Present at NobleConXV in Fort Lauderdale, Florida
Genprex Will Present and Participate in Panel Discussion at Upcoming NobleConXV Conference 
From Business Wire News Releases
Genprex to Present at Biotech Showcase™ 2019 in San Francisco
Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that it will present... 
From Business Wire News Releases
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags XBI DRRX MDCO
From Benzinga
Genprex to Launch Investors Website and Increase Emphasis on Investor Relations in 2019
Genprex, Inc. (NASDAQ: GNPX) a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it will be... 
From Business Wire News Releases
Genprex to Present at the 11th Annual LD Micro Main Event
Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that its Chairman... 
From Business Wire News Releases
The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags SNSS Earnings GTHX
From Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.